FMT decreases mortality in severe, fulminant C. diff

Compared with standard of care, fecal microbiota transplantation decreases mortality among patients with severe and fulminant Clostridioides difficile infection, according to study results.
Ari M. Grispan, MD, of the division of gastroenterology at Icahn School of Medicine at Mount Sinai, and colleagues wrote that few advances have been made in the treatment of severe and fulminant CDI, a condition associated with poor long-term outcomes.
“For cases of recurrent or refractory CDI, fecal microbiota transplant has been shown to be extremely efficacious,” they wrote. “However,

Source link

Related posts

NAFLD 2020: The State of the Disease


Abdominal abscesses in Crohn’s require surgery 70% of the time


Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World